LSU Health Sciences Center New Orleans

Our Lady of the Lake Health First in Nation to Implement Life-Saving Sepsis Detection Technology

Retrieved on: 
Mercoledì, Agosto 2, 2023

Sepsis is the leading cause of mortality in hospitals across the nation, accounting for 1 in 3 hospital deaths.

Key Points: 
  • Sepsis is the leading cause of mortality in hospitals across the nation, accounting for 1 in 3 hospital deaths.
  • “With clear and early detection, we are able to get patients the appropriate treatment, at the right time.
  • This technology will undoubtedly help save lives in Louisiana, across the nation and across the world.”
    Click here to access interviews and b-roll for your news coverage.
  • “Our Lady of the Lake Health has really led this work and research.

Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

Retrieved on: 
Martedì, Agosto 1, 2023

Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana, is the first U.S. medical center to adopt IntelliSep for emergency department (ED) use.

Key Points: 
  • Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana, is the first U.S. medical center to adopt IntelliSep for emergency department (ED) use.
  • The test aids in the rapid diagnosis of sepsis for adult patients with signs and symptoms of infection, providing results in under 10 minutes.
  • I’m really excited for what the future brings.”
    The IntelliSep test is a groundbreaking diagnostic tool that categorizes patients into three bands according to their probability of sepsis based on a standard blood draw.
  • The results may equip providers with a tool to optimize clinical outcomes and empower hospitals to improve resource utilization and achieve operational excellence.

Late-Breaking Data for Cytovale’s IntelliSep® Sepsis Test Further Validate its Potential to Aid in Rapid, Clinically Actionable Sepsis Diagnosis in Emergency Departments

Retrieved on: 
Lunedì, Maggio 22, 2023

These data were presented for the first time today as a late-breaking poster presentation at the American Thoracic Society (ATS) International Conference in Washington, DC.

Key Points: 
  • These data were presented for the first time today as a late-breaking poster presentation at the American Thoracic Society (ATS) International Conference in Washington, DC.
  • “These results validate the efficacy and efficiency of IntelliSep as a diagnostic aid that may improve sepsis triage when incorporated into existing clinical protocols."
  • In this study, which included 572 patients, the IntelliSep test identified three statistically distinct bands of sepsis probability with an increasing likelihood of sepsis.
  • Cytovale anticipates making the IntelliSep test commercially available within the next quarter.

Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies

Retrieved on: 
Mercoledì, Maggio 3, 2023

All of the parties involved are focused on using HOLO AI Insights with a goal to enhance clinical decision support and patient care through the use of artificial intelligence (AI).

Key Points: 
  • All of the parties involved are focused on using HOLO AI Insights with a goal to enhance clinical decision support and patient care through the use of artificial intelligence (AI).
  • HOLO AI Insights enables customers, partners, and clinical researchers to take advantage of the Company’s AI portfolio through a secure, highly scalable cloud platform for automated analysis of medical images.
  • Surgalign, in my opinion, is one of the most exciting given the groundbreaking work they are doing with artificial intelligence.
  • He is co-founder of The Spine Network (TSN), an organization dedicated to excellence and pioneering and integrating disruptive technologies, including AI, in Spine Research.

Steve Harvey Morning Show Co-Host Kier "Junior" Spates, a Sickle Cell Warrior, Hosts the New Inspiring Podcast, "Living Your Life"

Retrieved on: 
Lunedì, Aprile 17, 2023

The series, Living Your Life, brings attention to families and individuals thriving despite sickle cell disease or sickle cell trait.

Key Points: 
  • The series, Living Your Life, brings attention to families and individuals thriving despite sickle cell disease or sickle cell trait.
  • The podcast premiers Tuesday, April 18th and can be found on YouTube and at https://livingyourlife.online .
  • Each episode will provide positive lifestyle stories and information about sickle cell, including health care, travel, and food.
  • Living Your Life focuses on increasing awareness for sickle cell disease and improving patient outcome.

3D Systems Announces Appointment of Dr. Rebekah Gee as Member of its Medical Advisory Board

Retrieved on: 
Mercoledì, Febbraio 8, 2023

ROCK HILL, S.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the appointment of Dr. Rebekah Gee to the 3D Systems Medical Advisory Board, effective March 1, 2023.

Key Points: 
  • ROCK HILL, S.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the appointment of Dr. Rebekah Gee to the 3D Systems Medical Advisory Board, effective March 1, 2023.
  • Dr. Gee is a recognized expert on public health policy and was elected to the National Academy of Medicine in 2017.
  • The board’s primary mission is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine.
  • Commenting on her appointment, Dr. Jeffrey Graves, president and CEO of 3D Systems, stated, “It is my great pleasure to welcome Dr. Rebekah Gee to our Medical Advisory Board.

FDA Clears Cytovale’s® IntelliSep® Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools

Retrieved on: 
Mercoledì, Gennaio 18, 2023

IntelliSep is a groundbreaking diagnostic tool that helps clinicians recognize sepsis and supports critical time-sensitive clinical decisions, providing test results in under 10 minutes.

Key Points: 
  • IntelliSep is a groundbreaking diagnostic tool that helps clinicians recognize sepsis and supports critical time-sensitive clinical decisions, providing test results in under 10 minutes.
  • The first in a new class of ED-focused diagnostic tools that assess host response, the test is a simple, fast, and intuitive solution that provides actionable answers directly from a standard blood draw.
  • IntelliSep categorizes patients into three bands according to their probability of sepsis, with Band 1 indicating low probability of sepsis and Band 3 indicating high probability of sepsis.
  • "Every minute is crucial in identifying sepsis, and IntelliSep has the potential to transform clinical approaches to sepsis triage and diagnosis and save countless lives."

CHILDREN'S HOSPITALS ANNOUNCE AFFILIATION TO IMPROVE THE HEALTH OF A GENERATION

Retrieved on: 
Lunedì, Dicembre 19, 2022

Our Lady of the Lake Children's Health and Children's Hospital New Orleans will partner to improve access to specialized pediatric health services and child health outcomes.

Key Points: 
  • Our Lady of the Lake Children's Health and Children's Hospital New Orleans will partner to improve access to specialized pediatric health services and child health outcomes.
  • This month, agreement terms were finalized to establish the framework in which the two children's hospitals will collaborate in the delivery of pediatric health services.
  • The affiliation, which takes effect January 1, 2023, creates opportunities for immediate collaboration to improve access to and the quality of pediatric healthcare in Louisiana.
  • In recent years, both Children's Hospital New Orleans and Our Lady of the Lake Children's Health have made significant investments in the delivery of pediatric health services.

NCI NCORP-designated LSU Health New Orleans and ConcertAI Advance Multi-Year Collaboration Addressing Diversity in Clinical Trials

Retrieved on: 
Martedì, Settembre 27, 2022

NEW ORLEANS and CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ -- The National Cancer Institute Community Oncology Research Program (NCI NCORP)-designated Louisiana State University (LSU) Health New Orleans and ConcertAI, LLC (ConcertAI) announced a five-year partnership to improve the diversity of clinical trials and ensure broader clinical trial access throughout the Gulf South region.

Key Points: 
  • "LSU Health New Orleans and ConcertAI believe addressing disparities starts with a foundation of data and a diversity of clinical settings that explicitly assure the broadest representativeness and generalizability.
  • A $5.6 million grant from the NCI helped LSU Health New Orleans establish a clinical trials network throughout the Gulf South region.
  • LSU Health Sciences Center New Orleans (LSU Health New Orleans) educates Louisiana's health care professionals.
  • LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment or cure disease.

North Oaks Health System Announces Plans To Expand Specialized Pediatric Healthcare Services For Families Across Tangipahoa Parish And The Northshore Region Through Affiliation With Children’s Hospital New Orleans

Retrieved on: 
Lunedì, Settembre 19, 2022

The clinical affiliation builds upon existing services, which are provided by Childrens Hospital New Orleans at North Oaks Medical Center today, which include neonatology, pediatric hospitalist coverage and pediatric cardiology services.

Key Points: 
  • The clinical affiliation builds upon existing services, which are provided by Childrens Hospital New Orleans at North Oaks Medical Center today, which include neonatology, pediatric hospitalist coverage and pediatric cardiology services.
  • In the new affiliation agreement, the organizations will explore opportunities for Childrens Hospital to provide additional pediatric services at North Oaks, bringing specialized care for children closer to home for families.
  • Childrens Hospital New Orleans will provide professional medical services and oversight of the pediatric service line at North Oaks, with ongoing clinical collaboration.
  • Childrens Hospital and North Oaks look forward to working together on this initiative to advance health outcomes for the children and families of the Northshore Region.